| Prediction model for 30-day hospital readmissions among patients discharged receiving outpatient parenteral antibiotic therapy GM Allison, EG Muldoon, DM Kent, JK Paulus, R Ruthazer, A Ren, ... Clinical infectious diseases 58 (6), 812-819, 2014 | 131 | 2014 |
| Zoonotic transmission of Streptococcus equi subsp. zooepidemicus from a dog to a handler Y Abbott, E Acke, S Khan, EG Muldoon, BK Markey, M Pinilla, FC Leonard, ... Journal of medical microbiology 59 (1), 120-123, 2010 | 108 | 2010 |
| Two-stage arthroplasty for prosthetic joint infection: a systematic review of acute kidney injury, systemic toxicity and infection control A Luu, F Syed, G Raman, A Bhalla, E Muldoon, S Hadley, E Smith, M Rao The Journal of arthroplasty 28 (9), 1490-1498. e1, 2013 | 107 | 2013 |
| Aspergillus bronchitis without significant immunocompromise A Chrdle, S Mustakim, RJ Bright‐Thomas, CG Baxter, T Felton, ... Annals of the New York Academy of Sciences 1272 (1), 73-85, 2012 | 94 | 2012 |
| Delivering on antimicrobial resistance agenda not possible without improving fungal diagnostic capabilities DW Denning, DS Perlin, EG Muldoon, AL Colombo, A Chakrabarti, ... Emerging infectious diseases 23 (2), 177, 2017 | 92 | 2017 |
| Aspergillus nodules; another presentation of Chronic Pulmonary Aspergillosis EG Muldoon, A Sharman, I Page, P Bishop, DW Denning BMC pulmonary medicine 16, 1-9, 2016 | 81 | 2016 |
| Are we ready for an outpatient parenteral antimicrobial therapy bundle? A critical appraisal of the evidence EG Muldoon, DR Snydman, EC Penland, GM Allison Clinical infectious diseases 57 (3), 419-424, 2013 | 68 | 2013 |
| A national survey of infectious disease practitioners on their use of outpatient parenteral antimicrobial therapy (OPAT) EG Muldoon, K Switkowski, A Tice, DR Snydman, GM Allison Infectious Diseases 47 (1), 39-45, 2015 | 61 | 2015 |
| Impact of a diagnostics-driven antifungal stewardship programme in a UK tertiary referral teaching hospital R Rautemaa-Richardson, V Rautemaa, F Al-Wathiqi, CB Moore, L Craig, ... Journal of Antimicrobial Chemotherapy 73 (12), 3488-3495, 2018 | 53 | 2018 |
| Investigating the effect of antiretroviral switch to tenofovir alafenamide on lipid profiles in people living with HIV A Lacey, S Savinelli, EA Barco, A Macken, AG Cotter, G Sheehan, ... Aids 34 (8), 1161-1170, 2020 | 48 | 2020 |
| Treponema pallidum Azithromycin Resistance in Dublin, Ireland EG Muldoon, A Walsh, B Crowley, F Mulcahy Sexually Transmitted Diseases 39 (10), 784-786, 2012 | 46 | 2012 |
| Syphilis resurgence in Dublin, Ireland E Muldoon, F Mulcahy International journal of STD & AIDS 22 (9), 493-497, 2011 | 42 | 2011 |
| Allergic and noninvasive infectious pulmonary aspergillosis syndromes EG Muldoon, ME Strek, KC Patterson Clinics in chest medicine 38 (3), 521-534, 2017 | 38 | 2017 |
| Invasive pulmonary aspergillosis is associated with adverse clinical outcomes in critically ill patients receiving veno-venous extracorporeal membrane oxygenation I Rodriguez-Goncer, S Thomas, P Foden, MD Richardson, A Ashworth, ... European Journal of Clinical Microbiology & Infectious Diseases 37, 1251-1257, 2018 | 34 | 2018 |
| Outpatient parenteral antimicrobial therapy (OPAT) in the Republic of Ireland: results of a national survey EG Muldoon, GM Allison, D Gallagher, DR Snydman, C Bergin European journal of clinical microbiology & infectious diseases 32, 1465-1470, 2013 | 24 | 2013 |
| The impact of cefepime as first line therapy for neutropenic fever on Clostridium difficile rates among hematology and oncology patients EG Muldoon, L Epstein, T Logvinenko, S Murray, SI Doron, DR Snydman Anaerobe 24, 79-81, 2013 | 23 | 2013 |
| Characterisation of fatigue and its substantial impact on health status in a large cohort of patients with chronic pulmonary aspergillosis (CPA) K Al-Shair, EG Muldoon, J Morris, GT Atherton, C Kosmidis, DW Denning Respiratory Medicine 114, 117-122, 2016 | 22 | 2016 |
| Chronic fibrosing pulmonary aspergillosis: A cause of ‘destroyed lung’syndrome C Kosmidis, P Newton, EG Muldoon, DW Denning Infectious diseases 49 (4), 296-301, 2017 | 20 | 2017 |
| F508del CFTR gene mutation in patients with allergic bronchopulmonary aspergillosis MN Gamaletsou, G Hayes, C Harris, J Brock, EG Muldoon, DW Denning Journal of asthma 55 (8), 837-843, 2018 | 18 | 2018 |
| Can intravenous antifungal therapy be safely used in the outpatient parenteral antimicrobial therapy (OPAT) setting? N Rae, C Kenny, EG Muldoon Mycoses 62 (3), 196-203, 2019 | 17 | 2019 |
